Michael Rapp Net Worth & Insider Trades

Michael Rapp Zynerba Pharmaceuticals, Inc

As of May 31, 2018

What is Michael Rapp's Net Worth?

The current estimated net worth of Zynerba Pharmaceuticals, Inc's Michael Rapp is estimated to be about $4.06M . Michael Rapp owns about 1,500,000 units of Zynerba Pharmaceuticals, Inc common stock. In the last 3 years at Zynerba Pharmaceuticals, Inc, Michael Rapp has sold an estimated value of $0 worth.

What is Michael Rapp's Past Insider Trading?

Michael Rapp's largest purchase order was 100,000 units , worth over $973.74K on October 23, 2017. In total, Michael Rapp has made about 8 transactions over 3 years of their time at Zynerba Pharmaceuticals, Inc. Michael Rapp usually trades in May, with the busiest year in 2018. The most recent transaction was a purchase order of 5,885 units , worth over $61.5K on May 31, 2018.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Michael Rapp's Salary in 2020?

As an executive member of Zynerba Pharmaceuticals, Inc, Michael Rapp has a total base salary of $249,385 . Michael Rapp received compensation valued at about $936,806 in 2020. The vast majority of their compensation came in the form of other earnings, plans or compensations of $108,204 , option awards of $559,694 , and other compensation of $19,523 .

What is Michael Rapp's' Mailing Address?

  • Mailing address is 712 Fifth Avenue 49th Floor New York NY 10019 NY

Zynerba Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Other Earnings Plans or Compensations
Stock Awards
Option Awards
Other Compensation
Total
Armando Anido 2020 $585,265 $263,369 - $580,674 $53,441 $1,482,749
Armando Anido 2019 $568,218 $334,112 - $413,149 $54,092 $1,369,571
Terri B. Sebree 2020 $450,883 $209,660 - $428,858 $26,251 $1,115,652
Terri B. Sebree 2019 $437,750 $252,144 $13,140 $309,861 $25,985 $1,038,880
James E. 2020 $409,932 $129,129 - $303,775 $43,763 $886,599
James E. 2019 $390,411 $158,347 - $227,487 $47,862 $824,107
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1621443/000110465921052876/tm2111207-2_def14a.htm

What are Zynerba Pharmaceuticals, Inc's Past Insider Trades?

Zynerba Pharmaceuticals, Inc's most recent insider trade came on July 20, 2022 by Terri Sebree who sold 8,281 units worth $9.11K . In the last 7 years, insiders at Zynerba Pharmaceuticals, Inc have sold an estimated value of $65.38K and bought an estimated value of $2.45M worth of shares. Insider trading is most common in June, with the busiest year in 2018. The most active traders at the company are Kenneth Moch, Director,  William Federici, Director,  and Armando Anido, Chairman & CEO .

Zynerba Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1